Boosting immune response with GM-CSF optimizes primary cryotherapy outcomes in the treatment of prostate cancer: a prospective randomized clinical trial-Reference-Cited by-同舟云学术

Boosting immune response with GM-CSF optimizes primary cryotherapy outcomes in the treatment of prostate cancer: a prospective randomized clinical trial

Published:2021-02-08 Issue:3 Volume:24 Page:750-757
ISSN:1365-7852
Container-title:Prostate Cancer and Prostatic Diseases
language:en
Short-container-title:Prostate Cancer Prostatic Dis

Author:

Barqawi Al Baha^ORCID,Rodrigues Pessoa Rodrigo,Crawford E. David,Al-Musawi Mohammed,MacDermott Tracey,O’Donell Colin,Kendl Ross M.

Funder

Endocare Inc

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Urology,Oncology

Link

https://www.nature.com/articles/s41391-021-00321-8.pdf

Reference30 articles.

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7–34.

2. Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion. Science. 2011;331:1565–70.

3. Rekoske BT, McNeel DG. Immunotherapy for prostate cancer: false promises or true hope? Cancer. 2016;122:3598–607.

4. Rini BI, Fong L, Weinberg V, Kavanaugh B, Small EJ. Clinical and immunological characteristics of patients with serologic progression of prostate cancer achieving long-term disease control with granulocyte-macrophage colony-stimulating factor. J Urol. 2006;175:2087–91.

5. Amato RJ, Hernandez-McClain J, Henary H. Phase 2 study of granulocyte-macrophage colony-stimulating factor plus thalidomide in patients with hormone-naive adenocarcinoma of the prostate. Urol Oncol. 2009;27:8–13.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Irreversible electroporation of localised prostate cancer downregulates immune suppression and induces systemic anti‐tumour T‐cell activation – IRE‐IMMUNO study;BJU International;2024-08-05

2. Pre-exercise cryotherapy reduces myoglobin and creatine kinase levels after eccentric muscle stress in young women;Frontiers in Physiology;2024-06-19

3. Advances in bio-immunotherapy for castration-resistant prostate cancer;Journal of Cancer Research and Clinical Oncology;2023-07-18

4. Sustained release of alpha‐methylacyl‐CoA racemase (AMACR) antibody‐conjugated and free doxorubicin from silica nanoparticles for prostate cancer cell growth inhibition;Journal of Biomedical Materials Research Part B: Applied Biomaterials;2022-10-31

5. Boosting the Immune Response—Combining Local and Immune Therapy for Prostate Cancer Treatment;Cells;2022-09-07